SSEA-3 Antibodies

Santa Cruz Biotechnology offers a broad range of SSEA-3 monoclonal antibodies for advanced research in stem cell biology and developmental studies. SSEA-3 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SSEA-3, or Stage-Specific Embryonic Antigen 3, is a glycosphingolipid that plays a critical role in the identification and characterization of pluripotent stem cells. SSEA-3 is essential for understanding cell differentiation and development, making it a key focus in regenerative medicine and tissue engineering research. The presence of SSEA-3 serves as a marker for undifferentiated embryonic stem cells, highlighting its significance in stem cell research. Researchers frequently utilize SSEA-3 monoclonal antibodies to track stem cell populations and monitor differentiation states. Understanding SSEA-3 expression patterns helps advance knowledge in developmental biology and cellular reprogramming. SSEA-3 monoclonal antibodies enable detailed investigation of pluripotency mechanisms and stem cell maintenance. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing stem cell biology and therapeutic development.